Literature DB >> 14510817

Epilepsy, antiepileptic drugs (AEDs) and cognition.

E Hirsch1, B Schmitz, M Carreño.   

Abstract

People with epilepsy are at increased risk of cognitive deficits as a result of various factors: the effect of seizures themselves, psychosocial factors and adverse effects of AEDs. It is crucial that, following early diagnosis of the correct epileptic syndrome, patients are treated with the appropriate drugs, as incorrect AEDs can exacerbate symptoms. By discussing various epileptic syndromes and performing a broad review of the available evidence, it is possible to make recommendations concerning prescription of AEDs with respect to cognition. An interesting advance in this area is the increasing use of AEDs such as valproate (in some countries divalproex is indicated), carbamazepine or lamotrigine (lamotrigine has been filed for approval in this indication) for bipolar disorders. Children and the elderly are especially vulnerable to adverse effects on cognition. This review highlights advantages of valproate in these populations; it is well tolerated and produces few cognitive side effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14510817     DOI: 10.1034/j.1600-0404.108.s180.4.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  13 in total

Review 1.  Suicidality and antiepileptic drugs: is there a link?

Authors:  Vladimir V Kalinin
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 2.  Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors.

Authors:  Alkomiet Hasan; Amanda Mitchell; Anja Schneider; Tobias Halene; Schahram Akbarian
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-02-05       Impact factor: 5.270

Review 3.  Managing bipolar disorder in the elderly: defining the role of the newer agents.

Authors:  Martha Sajatovic; Subramoniam Madhusoodanan; Nicoleta Coconcea
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 4.  GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.

Authors:  Meng-Yi Xu; Albert H C Wong
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

5.  A neurocognitive endophenotype associated with rolandic epilepsy.

Authors:  Anna B Smith; Peregrine M Kavros; Tara Clarke; Nelson J Dorta; Geoffrey Tremont; Deb K Pal
Journal:  Epilepsia       Date:  2012-01-05       Impact factor: 5.864

Review 6.  Alternating and postictal psychoses: review and a unifying hypothesis.

Authors:  Perminder S Sachdev
Journal:  Schizophr Bull       Date:  2007-03-03       Impact factor: 9.306

7.  Thalamofrontal circuitry and executive dysfunction in recent-onset juvenile myoclonic epilepsy.

Authors:  Dalin T Pulsipher; Michael Seidenberg; Leslie Guidotti; Victoria N Tuchscherer; Jared Morton; Raj D Sheth; Bruce Hermann
Journal:  Epilepsia       Date:  2009-01-17       Impact factor: 5.864

8.  Glycine transporter 1 is a target for the treatment of epilepsy.

Authors:  Hai-Ying Shen; Erwin A van Vliet; Kerry-Ann Bright; Marissa Hanthorn; Nikki K Lytle; Jan Gorter; Eleonora Aronica; Detlev Boison
Journal:  Neuropharmacology       Date:  2015-08-21       Impact factor: 5.250

Review 9.  [Emotional and affective disorders, anxiety and personality disorders in epilepsies].

Authors:  E Pauli; H Stefan
Journal:  Nervenarzt       Date:  2009-12       Impact factor: 1.214

Review 10.  Impaired vigilance networks in temporal lobe epilepsy: Mechanisms and clinical implications.

Authors:  Dario J Englot; Victoria L Morgan; Catie Chang
Journal:  Epilepsia       Date:  2020-01-04       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.